
Fairtility
In vitro fertilization (IVF) has traditionally relied on embryologists manually evaluating embryos to determine their likelihood of resulting in a healthy pregnancy. Fairtility, an Israeli startup, is transforming this process with an AI platform that identifies key biological markers—helping embryologists select viable embryos and improve IVF outcomes for families.
To help this groundbreaking company stand out in a complex, high-tech category, Ascender partnered with Fairtility to rebrand the organization and define a clear market position—balancing scientific rigor with human impact.

Ascender began by uncovering a critical tension within the IVF community: while AI holds immense potential, many embryologists view it with skepticism—questioning its role, its reliability, and whether it might replace human expertise.
From this insight, we defined a unifying brand idea rooted in transparent AI—positioning Fairtility not as a disruptor of clinical judgment, but as a partner to it. By emphasizing accountability, ethicality, and fairness, we reframed the technology as something that enhances human expertise rather than competing with it.
This idea came to life through a visual system inspired by the microscopic world of cellular development—what we call the “geometry of creation.” A dynamic palette of vibrant, modular shapes reflects both the precision of science and the beauty of early life, creating a flexible and distinctive brand language across digital and physical touchpoints.
To personify Fairtility’s AI assistant, Ascender proposed the name “Chloe,” derived from the Greek for “green sprouts,” symbolizing fertility and new beginnings. Chloe embodies the brand’s promise of support and discovery—an AI that helps uncover patterns and possibilities otherwise invisible.
Chloe’s identity expands on the geometry of creation, with kaleidoscopic patterns suggesting endless evolution. This approach reinforces Fairtility’s commitment to transparency and empathy, presenting Chloe as a trusted collaborator in the IVF process.

Ascender translated the new brand into a comprehensive go-to-market ecosystem—defining Fairtility’s sales narrative and equipping the team with the tools to communicate it consistently across every touchpoint. From presentations and conference experiences to digital and social channels, we built a cohesive system that brings the brand to life in-market. The visual identity was designed for scalability, using a generative approach that enables rapid content creation while maintaining a distinctive and recognizable brand presence.



The digital presence received equal attention. We designed a modular, custom-built website that can grow alongside Fairtility’s ambitious roadmap. Interactive experiences—like a conference app where IVF professionals could test embryo-grading skills with and without Chloe’s guidance—brought the technology to life and encouraged engagement.


As Fairtility’s offering evolved, Ascender helped expand the brand’s focus beyond embryologists to engage broader clinic stakeholders—from the lab to leadership. To support this shift, we developed new storytelling tools that demonstrate Chloe’s value across the entire IVF ecosystem. A dynamic, interactive clinic diagram equips sales teams with an immersive way to illustrate how Chloe integrates into each stage of the IVF journey—highlighting its impact not only on embryo analysis, but on treatment planning, operational efficiency, and clinical decision-making.
Through strategy, design, and interactive technology, Ascender helped Fairtility articulate a compelling, human-centered narrative—one that conveys both cutting-edge innovation and the profound hope their AI brings to families worldwide.
Ideas are easy. Execution is where it matters.
We’re built for the part most teams struggle with — taking ideas out of decks and into the real world.
Work with us